Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPD489 (Vyvanse) in Adults with Binge Eating Disorder
NCT01291173Phase 2Completed
- Sponsor
- Takeda
- Start
- May 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lisdexamfetamine in binge eating disorder (BED), sponsored by Takeda. Started May 2011; status: completed.
02
Drugs
lisdexamfetamine
03
Conditions
binge eating disorder (BED)
Beyond the preview
Go deeper on NCT01291173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01291173.